Generative AI in Clinical Trial Market: Size, Growth, and Strategic Insights

The Generative AI in Clinical Trial industry is rapidly transforming the clinical research landscape by enhancing data analysis, patient monitoring, and trial design. Leveraging advanced AI models, stakeholders are witnessing accelerated drug development cycles and improved trial accuracy, signaling robust business growth ahead.

Market Size and Overview

The Global Generative AI in Clinical Trial Market size is estimated to be valued at USD 685.4 million in 2026 and is expected to reach USD 4,276.8 million by 2033, exhibiting a compound annual growth rate (CAGR) of 29% from 2026 to 2033.

The significant market growth is driven by rising demand for efficient clinical trial protocols and the integration of AI-enabled platforms. Market insights indicate escalating adoption of generative AI for predictive analytics and patient recruitment optimization, which widens the market scope and supports rapid industry expansion.

Read full blog on our website:
https://www.coherentmarketinsi....ghts.com/industry-re

#coherentmarketinsights #generativeaiinclinicaltrialmarket #drugdiscovery #medtech #healthtech #pharmaindustry #biotech #healthcareinnovation